Easterly Investment Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.86M Buy
75,835
+12,954
+21% +$1.19M 0.52% 51
2025
Q4
$5.65M Sell
62,881
-2,010
-3% -$191K 0.35% 74
2025
Q3
$6.39M Buy
64,891
+655
+1% +$64.9K 0.43% 69
2025
Q2
$5.86M Sell
64,236
-2,269
-3% -$219K 0.42% 74
2025
Q1
$7.53M Buy
66,505
+1,273
+2% +$136K 0.63% 58
2024
Q4
$6.89M Sell
65,232
-7,349
-10% -$789K 0.54% 66
2024
Q3
$7.84M Sell
72,581
-136
-0.2% -$14.8K 0.63% 56
2024
Q2
$7.89M Sell
72,717
-22,455
-24% -$2.65M 0.69% 57
2024
Q1
$12.6M Buy
95,172
+2,196
+2% +$274K 0.96% 33
2023
Q4
$11.3M Sell
92,976
-12,896
-12% -$1.44M 1.21% 33
2023
Q3
$11.9M Buy
105,872
+20,189
+24% +$2.56M 1.31% 23
2023
Q2
$12.5M Sell
85,683
-1,379
-2% -$187K 1.1% 27
2023
Q1
$11.2M Buy
87,062
+1,601
+2% +$201K 0.99% 38
2022
Q4
$10.9M Sell
85,461
-9,644
-10% -$1.12M 0.94% 41
2022
Q3
$9.94M Sell
95,105
-8,851
-9% -$971K 0.95% 39
2022
Q2
$10.9M Sell
103,956
-1,197
-1% -$142K 0.97% 39
2022
Q1
$13.4M Buy
105,153
+13,511
+15% +$1.63M 1.02% 39
2021
Q4
$11.3M Buy
+91,642
New +$12M 0.82% 54

Other funds holding ZBH

Easterly Investment Partners's ZBH Position: Q1 2026 in Review

Easterly Investment Partners increased its Zimmer Biomet (ZBH) stake by 21% in Q1 2026, buying an estimated $1.19M and bringing the position to 75,835 shares worth $6.86M. The position accounts for 0.52% of the portfolio, ranked #51.

Easterly Investment Partners first reported a position in ZBH in Q4 2021 and has held it in 18 quarters since. The position peaked at $13.4M in Q1 2022. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Easterly Investment Partners held 75,835 shares of Zimmer Biomet worth $6.86M as of Q1 2026.
  • Easterly Investment Partners bought 12,954 Zimmer Biomet shares in Q1 2026, an estimated $1.19M.
  • Zimmer Biomet made up 0.52% of Easterly Investment Partners's portfolio in Q1 2026, its #51 holding.
  • Easterly Investment Partners first reported a position in Zimmer Biomet in Q4 2021 and has held it in 18 quarters since.
  • Easterly Investment Partners's Zimmer Biomet position peaked at $13.4M in Q1 2022.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Easterly Investment Partners's 13F filing for Q1 2026, filed 11 May 2026.